Trial Profile
A Prospective Randomized Study of QD vs BID Dosing in ART
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Menotropin (Primary) ; Urofollitropin (Primary)
- Indications Infertility
- Focus Therapeutic Use
- 13 Jan 2010 Planned end date changed from 1 Dec 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 21 Oct 2009 Results were reported at the 65th Annual Meeting of the American Society for Reproductive Medicine.
- 21 Oct 2009 Status changed from recruiting to completed based on results being reported at the 65th Annual Meeting of the American Society for Reproductive Medicine.